STAT+: Civica Rx considers moving into chemo drugs as shortages worsen
WASHINGTON — A nonprofit formed by hospitals to deal with drug shortages is considering a…
Category: Medicine
Novelist John Green launches attack on Cepheid over the price of its TB test
John Green, a novelist and high-profile YouTuber, is once again leveraging his star power in…
Opinion: Long Covid is a new name for an old syndrome
Long Covid goes by many names. Today, it is no longer a new public health enigma,…
STAT+: FDA panel endorses Alnylam’s heart drug — after picking apart its supporting data
A group of advisers to the Food and Drug Administration voted in favor of Alnylam…
STAT+: What to make of Biden’s latest cancer moonshot efforts
WASHINGTON — The next chapter of President Biden’s moonshot to end cancer has landed. While…
STAT+: Akili abandons prescription business model, to lay off 40% of workers
Akili Interactive, which in 2020 made waves by receiving Food and Drug Administration clearance for…
STAT+: Lawmakers introduce bill to require drugmakers to provide key info to both FDA and U.S. Patent Office
Amid concerns over monopolies held by drugmakers, a bipartisan group of lawmakers introduced a bill…
STAT+: In new Regeneron deal for Covid drug, Biden administration imposes price limits for first time
WASHINGTON — A groundbreaking clause in a new deal between the Department of Health and…
STAT+: Pharmalittle: FDA panel says popular decongestant doesn’t work; U.S. warns companies over illegally marketed eye products
Good morning, everyone, and how are you today? We are doing just fine, thank you….
Opinion: PEPFAR, one of the greatest public health inventions of our time, is at risk
In the clinic where I work, I met a patient the other day whom I…
Opinion: STAT+: The IRA needs changes to better support patients with rare diseases
This time last year, members of Congress were working around the clock to draft and…
STAT+: How Silicon Valley’s hospital whisperer bridges the gap between startups and health systems
SAN FRANCISCO — As part of one of the tech industry’s most revered venture funds,…
They’re immigrants, farmworkers, and new moms. And they’re facing postpartum depression at higher rates
Over more than a decade working with immigrant farmworkers in the public clinics of the…
New Covid vaccine is recommended by CDC for everyone 6 months or older
A panel of advisers to the Centers for Disease Control and Prevention voted 13-1 Tuesday…
Food companies to regulators: Please don’t worry about ultra-processed anything
WASHINGTON — The food industry is anxious that regulators are focusing too much on the…
STAT+: White House touts efforts to stem cancer drug shortages
WASHINGTON — The White House says it’s working to end shortages of three key generic…
STAT+: Neurocrine Biosciences drug for congenital adrenal hyperplasia succeeds in late-stage trial
SAN DIEGO — Neurocrine Biosciences announced on Tuesday that an experimental drug for congenital adrenal…
Popular nasal decongestant doesn’t actually relieve congestion, FDA experts say
WASHINGTON — The leading decongestant used by millions of Americans looking for relief from a…
STAT+: Walmart may buy concierge Medicare Advantage provider ChenMed. But will it scale?
Walmart seems poised to increase its health care footprint by buying value-based senior care company…
Is there a path forward for PEPFAR?
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…
STAT+: Pharmalittle: Is Pascal Soriot leaving AstraZeneca? PBMs try to counter congressional crackdown
Hello, everyone, and nice to see you again after our extended break. A little time…
STAT+: Nick Leschly departs Bluebird Bio spinout amid restructuring, layoffs
Some two years after splitting biotech company Bluebird Bio into two entities in a bid…
STAT+: New obesity drugs are in the works trying to out-blockbuster Wegovy and Mounjaro
The exploding popularity of drugs like Wegovy and Mounjaro has propelled dozens of companies to…
Opinion: Patients might finally receive practical information with prescriptions — if the FDA doesn’t blow it
Patients often ask two questions about every medical treatment: Will it help me? Will it…
.jpg)
The food industry has tried to stack a key nutrition policy panel with its preferred experts, documents show
WASHINGTON — There’s a panel of 20 nutrition experts that has outsized influence on the…
STAT+: Here are the dozens of weight loss drugs in development to catch a booming market
The blazing success of weight loss drugs like Wegovy and Mounjaro has electrified the pursuit…
STAT+: FDA proposes changes to key approval pathway for medical devices, five years after promising
Five years after promising to fix a flawed regulatory pathway widely used by medical device…
STAT+: Acelyrin, a rare IPO success, stumbles in its first big test
The biotech company Acelyrin, which raised more than $500 million in an IPO this year,…
FDA approves updated Covid-19 vaccines
The Food and Drug Administration announced Monday that it had greenlit two updated Covid-19 booster shots…
STAT+: Pharmalittle: Biden’s NIH nominee will get a hearing; top Democrat backs bill to ban PBM spread pricing
Good morning, Jason Mast here filling in for Ed. Today, I’m drinking a cup of…
As kids, they underwent a common test for UTIs. As adults, it haunts them as a traumatic ‘nightmare’
This story contains descriptions of an invasive medical procedure and mention of sexual assault. It’s…
STAT+: Experts fear private equity will pour gas on cardiology’s overuse problem
Coronary stenting is, by some measures, the most overused procedure in hospitals. The problem costs…
Opinion: Doctors in the U.S. can learn a lot about advocacy and activism from their Israeli counterparts
Israeli doctors are bracing for a fight. On Sept. 12, the Israeli Supreme Court is…
Amid another rise in cases, Covid’s new normal has set in
Among people who are still paying attention to Covid-19, there’s been a recent surge —…
STAT+: Crinetics acromegaly drug succeeds in late-stage trial but would face stiff competition if approved
SAN DIEGO — Crinetics Pharmaceuticals announced on Sunday that its experimental drug for acromegaly, a…
NIH nominee Bertagnolli will get a confirmation hearing next month, Sanders says
WASHINGTON — Sen. Bernie Sanders (I-Vt.) will hold a confirmation hearing next month for Monica…
STAT+: House transparency, PBM reform bill gains bipartisan support
WASHINGTON — A Democrat has signed on to a legislative package that would require health…
How Seth Rogen and Lauren Miller Rogen are using comedy to support Alzheimer’s care
Alzheimer’s isn’t funny. But comedy can still be a weapon in the fight against this…
How Seth Rogen and Lauren Miller Rogan are using comedy to support Alzheimer’s care
Alzheimer’s isn’t funny. But comedy can still be a weapon in the fight against this…
STAT+: Lawsuit raises antitrust and kickback allegations around cancer patient referrals
A large independent group of oncologists in Philadelphia is suing the area’s dominant hospital system,…
Obesity-related cardiovascular deaths tripled in the last two decades, new study finds
Heart disease is killing fewer Americans overall, however, cardiovascular deaths where obesity was listed as…
.jpg)
STAT+: Pharmalittle: Novartis R&D hub’s name change reflects strategy shift; Lilly’s Mounjaro backed by U.K. watchdog
Good morning, Pharmalittle family! Adam Feuerstein here, filling in for Ed. My morning coffee was…
ALS advocates say criticism of new drugs misses bigger picture
A diagnosis of ALS has long been seen as a death sentence. But in recent…
How a supplement company became a haven for health misinformation
On a Friday afternoon in July, as many New Yorkers fled the scorching city streets,…
STAT+: Why Novartis is changing the name of its research labs
Swiss drugmaker Novartis’ research and development hub has a new name — and a new…
An uncommon thyroid diagnosis led to an unexpected, all-too-visible side effect
Annie Larsson, 40, is no stranger to chronic conditions. She was diagnosed with type 1…
Opinion: STAT+: Sanofi CEO Paul Hudson: The right way to bring AI into pharma
While it’s widely accepted that the pharma industry is innovative in R&D, it is also…
Opinion: How the drug price negotiation program could affect Medicare Part D beneficiaries
After the recent announcement of the first 10 drugs selected for Medicare price negotiation, much…
Group behind ProMED fires three top moderators amid strike
The organization that runs the infectious diseases surveillance system ProMED terminated at least three of…
Back to school for biotech, Biogen’s potential pivot, & Illumina’s next chapter
Are there still too many biotech companies? How do you know when you’re in a…